BIOS

BioPlus Acquisition Corp. Class A Ordinary Shares

Delisted

BIOS was delisted on the 6th of October, 2023.

61 hedge funds and large institutions have $231M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 10 closing their positions.

Holders
61
Holders Change
-5
Holders Change %
-7.58%
% of All Funds
0.98%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
11
Reduced
14
Closed
10
Calls
$104K
Puts
Net Calls
+$104K
Net Calls Change
+$1K
Name Holding Trade Value Shares
Change
Shares
Change %
OAC
51
OMERS Administration Corp
Ontario, Canada
$376K
Walleye Trading
52
Walleye Trading
New York
$376K
CM
53
Cohanzick Management
New York
$315K
RCM
54
Robinson Capital Management
Michigan
$313K
TI
55
Tidal Investments
Wisconsin
$305K
DCM
56
Dupont Capital Management
Delaware
$261K
ASM
57
ATW SPAC Management
New York
$216K
VF
58
Virtu Financial
New York
$147K +$28.1K +2,698 +24%
KIM
59
Karpus Investment Management
New York
$107K -$31.6K -3,025 -23%
LCM
60
Lynwood Capital Management
Ontario, Canada
$104K
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$2K -$11K -800 -85%
HCM
62
Highbridge Capital Management
New York
-$15.2M -1,482,836 Closed
Marshall Wace
63
Marshall Wace
United Kingdom
-$5.16M -502,350 Closed
SC
64
Sculptor Capital
New York
-$5.11M -500,100 Closed
TCA
65
Taconic Capital Advisors
New York
-$5.14M -500,000 Closed
HSBC Holdings
66
HSBC Holdings
United Kingdom
-$1.49M -145,000 Closed
SFM
67
Spartan Fund Management
Canada
-$763K -74,485 Closed
SAMU
68
SONA Asset Management (US)
New York
-$307K -30,000 Closed
PP
69
Paloma Partners
Connecticut
-$206K -20,000 Closed
UBS Group
70
UBS Group
Switzerland
-$11.9K -1,160 Closed
TRCT
71
Tower Research Capital (TRC)
New York
-$1K -92 Closed